Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

Publications

Date Source Title
Dec 28, 2020
Source
European Journal of Hematology
Dec 07, 2020
Source
ASH 2020 Annual Meeting
Dec 07, 2020
Source
ASH 2020 Annual Meeting
Dec 07, 2020
Source
ASH 2020 Annual Meeting
Dec 06, 2020
Source
ASH 2020 Annual Meeting
Dec 05, 2020
Source
ASH 2020 Annual Meeting
Jun 12, 2020
Source
EHA Annual Congress 2020
Jun 12, 2020
Source
EHA Annual Congress 2020
Dec 09, 2019
Source
2019 ASH Annual Meeting
Dec 09, 2019
Source
2019 ASH Annual Meeting
Dec 09, 2019
Source
2019 ASH Annual Meeting
Dec 08, 2019
Source
2019 ASH Annual Meeting
Dec 08, 2019
Source
2019 ASH Annual Meeting
Dec 08, 2019
Source
2019 ASH Annual Meeting
Dec 07, 2019
Source
2019 ASH Annual Meeting
Sep 04, 2019
Source
New England Journal of Medicine
Dec 03, 2018
Source
2018 ASH Annual Meeting
Jun 15, 2018
Source
EHA 2018
Jun 15, 2018
Source
EHA 2018
Dec 11, 2017
Source
2017 ASH Annual Meeting
Dec 10, 2017
Source
2017 ASH Annual Meeting
Jul 31, 2017
Source
Blood
Jun 24, 2017
Source
22nd EHA Congress
Dec 04, 2016
Source
58th ASH Annual Meeting
Dec 04, 2016
Source
58th ASH Annual Meeting
Dec 04, 2016
Source
58th ASH Annual Meeting
Jun 11, 2016
Source
21st EHA Congress
Jun 10, 2016
Source
21st EHA Congress

 

For details on our former oncology programs, visit https://www.servier.us/.